Myoglobin-loaded gadolinium nanotexaphyrins for oxygen synergy and imaging-guided radiosensitization therapy
Xiaotu Ma,
Xiaolong Liang,
Meinan Yao,
Yu Gao,
Qi Luo,
Xiaoda Li,
Yue Yu,
Yining Sun,
Miffy H. Y. Cheng,
Juan Chen,
Gang Zheng (),
Jiyun Shi () and
Fan Wang ()
Additional contact information
Xiaotu Ma: Chinese Academy of Sciences
Xiaolong Liang: Peking University Third Hospital
Meinan Yao: Peking University
Yu Gao: Chinese Academy of Sciences
Qi Luo: Guangzhou National Laboratory
Xiaoda Li: Peking University
Yue Yu: Chinese Academy of Sciences
Yining Sun: Chinese Academy of Sciences
Miffy H. Y. Cheng: University Health Network
Juan Chen: University Health Network
Gang Zheng: University Health Network
Jiyun Shi: Chinese Academy of Sciences
Fan Wang: Chinese Academy of Sciences
Nature Communications, 2023, vol. 14, issue 1, 1-17
Abstract:
Abstract Gadolinium (Gd3+)-coordinated texaphyrin (Gd-Tex) is a promising radiosensitizer that entered clinical trials, but temporarily fails largely due to insufficient radiosensitization efficacy. Little attention has been given to using nanovesicles to improve its efficacy. Herein, Gd-Tex is transformed into building blocks “Gd-Tex-lipids” to self-assemble nanovesicles called Gd-nanotexaphyrins (Gd-NTs), realizing high density packing of Gd-Tex in a single nanovesicle and achieving high Gd-Tex accumulation in tumors. To elucidate the impact of O2 concentration on Gd-Tex radiosensitization, myoglobin (Mb) is loaded into Gd-NTs (Mb@Gd-NTs), resulting in efficient relief of tumor hypoxia and significant enhancement of Gd-Tex radiosensitization, eventually inducing the obvious long-term antitumor immune memory to inhibit tumor recurrence. In addition to Gd3+, the versatile Mb@Gd-NTs can also chelate 177Lu3+ (Mb@177Lu/Gd-NTs), enabling SPECT/MRI dual-modality imaging for accurately monitoring drug delivery in real-time. This “one-for-all” nanoplatform with the capability of chelating various trivalent metal ions exhibits broad clinical application prospects in imaging-guided radiosensitization therapy.
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-023-41782-w Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41782-w
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-023-41782-w
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().